Jingxiao Wang

Years Active: 2019-2022
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Simiao Yu, Jingxiao Wang, Hao-Cheng Zheng, Ruilin Wang, Nadia Johnson, Tao Li, Ping Li, Jie Lin, Yuan Li, Jin Yan, Ying Zhang, Zhenyu Zhu, Xia Ding
Pathogenesis from Inflammation to Cancer in NASH-Derived HCC. Journal of hepatocellular carcinoma 9 (2022)
Xianqiong Liu, Junjie Hu, Xinhua Song, Kirsten Utpatel, Yi Zhang, Pan Wang, Xinjun Lu, Jie Zhang, Meng Xu, Tao Su, Li Che, Jingxiao Wang, Matthias Evert, Diego F Calvisi, Xin Chen
Combined Treatment with MEK and mTOR Inhibitors is Effective in In Vitro and In Vivo Models of Hepatocellular Carcinoma. Cancers 11 (7) (2019)

Jingxiao Wang.css-eqlu8i{font-size:small;padding-left:4px;}